» Articles » PMID: 23575689

Prostaglandin E₂ Promotes Th1 Differentiation Via Synergistic Amplification of IL-12 Signalling by CAMP and PI3-kinase

Overview
Journal Nat Commun
Specialty Biology
Date 2013 Apr 12
PMID 23575689
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

T helper 1 (Th1) cells have critical roles in various autoimmune and proinflammatory diseases. cAMP has long been believed to act as a suppressor of IFN-γ production and Th1 cell-mediated immune inflammation. Here we show that cAMP actively promotes Th1 differentiation by inducing gene expression of cytokine receptors involved in this process. PGE2 signalling through EP2/EP4 receptors mobilizes the cAMP-PKA pathway, which induces CREB- and its co-activator CRTC2-mediated transcription of IL-12Rβ2 and IFN-γR1. Meanwhile, cAMP-mediated suppression of T-cell receptor signalling is overcome by simultaneous activation of PI3-kinase through EP2/EP4 and/or CD28. Loss of EP4 in T cells restricts expression of IL-12Rβ2 and IFN-γR1, and attenuates Th1 cell-mediated inflammation in vivo. These findings clarify the molecular mechanisms and pathological contexts of cAMP-mediated Th1 differentiation and have clinical and therapeutic implications for deployment of cAMP modulators as immunoregulatory drugs.

Citing Articles

Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis.

Ngai D, Sukka S, Tabas I Front Immunol. 2024; 15:1403150.

PMID: 38873597 PMC: 11169609. DOI: 10.3389/fimmu.2024.1403150.


Pathogenesis of chronic enteropathy associated with the gene: Hypotheses and conundrums.

Xie Z, Li Y, Yang A, Wu D, Wang Q World J Gastroenterol. 2024; 30(19):2505-2511.

PMID: 38817656 PMC: 11135407. DOI: 10.3748/wjg.v30.i19.2505.


Prostaglandin E controls the metabolic adaptation of T cells to the intestinal microenvironment.

Villa M, Sanin D, Apostolova P, Corrado M, Kabat A, Cristinzio C Nat Commun. 2024; 15(1):451.

PMID: 38200005 PMC: 10781727. DOI: 10.1038/s41467-024-44689-2.


Soluble adenylyl cyclase contributes to imiquimod-mediated inflammation and is a potential therapeutic target in psoriasis.

You J, Reilly M, Eljalby M, Bareja R, Yusupova M, Vyas N Exp Dermatol. 2023; 32(7):1051-1062.

PMID: 37039485 PMC: 10523866. DOI: 10.1111/exd.14811.


Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.

Bender M, McPherson A, Phelps C, Pandey S, Laughlin C, Shapira J Cell. 2023; 186(9):1846-1862.e26.

PMID: 37028428 PMC: 10148916. DOI: 10.1016/j.cell.2023.03.011.


References
1.
Chen Q, Muramoto K, Masaaki N, Ding Y, Yang H, Mackey M . A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. Br J Pharmacol. 2010; 160(2):292-310. PMC: 2874852. DOI: 10.1111/j.1476-5381.2010.00647.x. View

2.
Mayr B, Montminy M . Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001; 2(8):599-609. DOI: 10.1038/35085068. View

3.
Zhu J, Paul W . CD4 T cells: fates, functions, and faults. Blood. 2008; 112(5):1557-69. PMC: 2518872. DOI: 10.1182/blood-2008-05-078154. View

4.
Kammer G . The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today. 1988; 9(7-8):222-9. DOI: 10.1016/0167-5699(88)91220-0. View

5.
Liao W, Lin J, Wang L, Li P, Leonard W . Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol. 2011; 12(6):551-9. PMC: 3304099. DOI: 10.1038/ni.2030. View